ArticleCurrent cancer drug targets2025

GAPVD1 Promotes the Proliferation of Triple-negative Breast Cancer Cells by Regulating the ERK/MAPK Signaling Pathway.

Lu Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.